Evidence map›Paper›PMID 21957995›Full record

ArticleBiochemistry2011

Novel insights into the biotin carboxylase domain reactions of pyruvate carboxylase from Rhizobium etli.

Tonya N Zeczycki, Ann L Menefee, Abdussalam Adina-Zada, Sarawut Jitrapakdee, Kathy H Surinya, John C Wallace, Paul V Attwood, Martin St Maurice, W Wallace Cleland

Abstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Structure and function of biotin-dependent carboxylases.Cellular and molecular life sciences : CMLS · 2013
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Tonya N ZeczyckiInstitute for Enzyme Research and Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53726, United States.
Ann L Menefee
Abdussalam Adina-Zada
Sarawut Jitrapakdee
Kathy H Surinya
John C Wallace
Paul V Attwood
Martin St Maurice
W Wallace Cleland
Marquette University · USUniversity of Adelaide · AUUniversity of Western Australia · AUUniversity of Wisconsin–Madison · USMahidol University · TH

Funding

The structure and function of pyruvate carboxylaseR01GM070455 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI RAYMENT, IVAN · 2005 to 2012
$2.7M
An Investigation of the Chemical and Catalytic Mechanism of Pyruvate CarboxylaseF32DK083898 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI ZECZYCKI, TONYA NICOLE · 2009 to 2012
$141k
NIDDK NIH HHS F32 DK083898NIDDK NIH HHS F32DK083898NIGMS NIH HHS GM070455NIGMS NIH HHS R01 GM070455
6 · The paper itself

Abstract

The catalytic mechanism of the MgATP-dependent carboxylation of biotin in the biotin carboxylase domain of pyruvate carboxylase from R. etli (RePC) is common to the biotin-dependent carboxylases. The current site-directed mutagenesis study has clarified the catalytic functions of several residues proposed to be pivotal in MgATP-binding and cleavage (Glu218 and Lys245), HCO(3)(-) deprotonation (Glu305 and Arg301), and biotin enolization (Arg353). The E218A mutant was inactive for any reaction involving the BC domain and the E218Q mutant exhibited a 75-fold decrease in k(cat) for both pyruvate carboxylation and the full reverse reaction. The E305A mutant also showed a 75- and 80-fold decrease in k(cat) for both pyruvate carboxylation and the full reverse reaction, respectively. While Glu305 appears to be the active site base which deprotonates HCO(3)(-), Lys245, Glu218, and Arg301 are proposed to contribute to catalysis through substrate binding interactions. The reactions of the biotin carboxylase and carboxyl transferase domains were uncoupled in the R353M-catalyzed reactions, indicating that Arg353 may not only facilitate the formation of the biotin enolate but also assist in coordinating catalysis between the two spatially distinct active sites. The 2.5- and 4-fold increase in k(cat) for the full reverse reaction with the R353K and R353M mutants, respectively, suggests that mutation of Arg353 allows carboxybiotin increased access to the biotin carboxylase domain active site. The proposed chemical mechanism is initiated by the deprotonation of HCO(3)(-) by Glu305 and concurrent nucleophilic attack on the γ-phosphate of MgATP. The trianionic carboxyphosphate intermediate formed reversibly decomposes in the active site to CO(2) and PO(4)(3-). PO(4)(3-) then acts as the base to deprotonate the tethered biotin at the N(1)-position. Stabilized by interactions between the ureido oxygen and Arg353, the biotin-enolate reacts with CO(2) to give carboxybiotin. The formation of a distinct salt bridge between Arg353 and Glu248 is proposed to aid in partially precluding carboxybiotin from reentering the biotin carboxylase active site, thus preventing its premature decarboxylation prior to the binding of a carboxyl acceptor in the carboxyl transferase domain.

Indexed as

Adenosine TriphosphateBacterial ProteinsBiotinCarbon-Nitrogen LigasesCatalytic DomainKineticsModels, MolecularMutagenesis, Site-DirectedOxaloacetic AcidProtein Structure, QuaternaryProtein Structure, TertiaryPyruvate CarboxylaseRecombinant ProteinsRhizobium etliAdenosine TriphosphateBacterial ProteinsBiotinbiotin carboxylaseCarbon-Nitrogen LigasesOxaloacetic AcidPyruvate CarboxylaseRecombinant Proteins

Identifiers

PMID21957995
PMCPMC3211089
OpenAlexW2157568495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.